EUCTR2014-004058-32-GB进行中（未招募）1 期
The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary Fibrosis with the Addition of Co-trimoxazole (EME-TIPAC) - Treating pulmonary fibrosis with co-trimoxazole
orfolk and Norwich University Hospital NHS Foundation Trust0 个研究点目标入组 330 人开始时间: 2015年6月12日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 330
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1)Male or female, aged greater than or equal to 40 years. IPF rarely occurs in individuals less than 40 years. Individuals younger than this more frequently have connective tissue related lung disease which is similar to but different from IPF.
- •2)A diagnosis of idiopathic pulmonary fibrosis (IPF) based on multi-disciplinary consensus according to the latest international guidelines within 2 years of enrolment into the study. Patients with a diagnosis of more than 2 years duration can be enrolled if they have evidence of progressive disease defined as =10% decline in forced vital capacity (FVC) or =15% decline in diffusing capacity of carbon monoxide over the preceding 6 or 12 months.
- •3)Patients may receive oral prednisolone up to a dose of 10 mg per day, anti-oxidant therapy, pirfenidone or other licensed medication for IPF e.g. nintedanib. Patients should be on a stable treatment regimen for at least 6 weeks to ensure baseline values are representative.
- •4)MRC dyspnoea score of greater than 1.
- •5)Able to provide informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 200
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 130
排除标准
- •1)FVC > 70% predicted.
- •2)A recognised significant co-existing respiratory disease, defined as a respiratory condition that exhibits a greater clinical effect on respiratory symptoms and disease progression than IPF as determined by the principal investigator.
- •3)Patients with airways disease defined as forced expiratory volume in 1 second (FEV1)/FVC<60%
- •4)A self-reported respiratory tract infection within 4 weeks of screening defined as two or more of cough, sputum or breathlessness and requiring antimicrobial therapy.
- •5)Significant medical, surgical or psychiatric disease that in the opinion of the patient’s attending physician would affect subject safety or influence the study outcome including liver (Serum transaminase > 3 x upper limit of normal (ULN), Bilirubin > 2 x ULN) and renal failure (creatinine clearance <30ml/min).
- •6)Patients receiving recognised immunosuppressant medication (except prednisolone above) including azathioprine and mycophenolate mofetil.
- •7)Female subjects must be of non-childbearing potential, defined as follows: postmenopausal females who have had at least 12 months of spontaneous amenorrhea or 6 months of spontaneous amenorrhoea with serum FSH>40mIU/ml or females who have had a hysterectomy or bilateral oophorectomy at least 6 weeks prior to enrolment.
- •8)Allergy or intolerance to trimethoprim or sulphonamides or their combination.
- •9)Untreated folate or B12 deficiency.
- •10)Known glucose-6-phosphate dehydrogenase (G6PD) deficiency or G6PD deficiency measured at screening in males of African, Asian or Mediterranean descent.
- •11)Receipt of an investigational drug or biological agent within the 4 weeks prior to study entry or 5 times the half-life if longer.
研究者
相似试验
进行中（未招募）
不适用
EVALUATION OF THE EFFICACY OF THE TREATMENT WITH ACE-INHIBITORS ON THE RENAL DAMAGE IN PATIENTS AFFECTED BY GLYCOGEN STORAGE DISEASE TYPE 1 AND OF THE VITAMINE E ON NEUTROPENIA OF PATIENTS WITH GSD1b - GSD1: study of specific therapeutic interventioEUCTR2006-005449-12-ITDipartimento di Pediatria
招募中
不适用
Comparison of the effect of TDCS and RTMS in the treatment of migraineMigraineIRCT20190404043159N4Esfahan University of Medical Sciences72
尚未招募
不适用
Study on parameters and efficacy of treatment with denosumab for bone metastases of prostate cancerJPRN-UMIN000009985Gifu University30
已完成
2 期
Treatment of schizophrenia with antipsychotic drugsSchizopherenia.SchizophreniaIRCT138706051100N1Deputy of Research, Tehran University of Medical Sciences28
已完成
2 期
Evaluation of the therapeutic effects of Iranian Traditional Medicine (Hab Shabyar) in patients with open-angle glaucoma: A double-blind clinical trialopen-angle glaucoma.Primary open-angle glaucomaIRCT2016052828127N1Vice Chancellor for Research (VCR) of Tabriz University of Medical Sciences50